RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. The company designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
How did RXST's recent EPS compare to expectations?
The most recent EPS for Rxsight Inc is $-0.38, beating expectations of $-0.28.
How did Rxsight Inc RXST's revenue perform in the last quarter?
Rxsight Inc revenue for the last quarter is $-0.38
What is the revenue estimate for Rxsight Inc?
According to 11 of Wall street analyst, the revenue estimate of Rxsight Inc range from $34.54M to $30.77M
What's the earning quality score for Rxsight Inc?
Rxsight Inc has a earning quality score of B+/52.198586. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Rxsight Inc report earnings?
Rxsight Inc next earnings report is expected in 2026-08-04
What are Rxsight Inc's expected earnings?
Rxsight Inc expected earnings is $30.33M, according to wall-street analysts.
Did Rxsight Inc beat earnings expectations?
Rxsight Inc recent earnings of $30.89M beat expectations.